Alternatives to InSightive

The ARIA® oncology information system is designed to assist both medical and radiation oncology practitioners, including those utilizing proton therapy. It enables the review of clinical images, prescriptions, lab results, quality assurance, treatment outcomes, and much more. Additionally, it automates cancer staging in accordance with AJCC guidelines and allows for flexible management of treatment toxicities. With a strong emphasis on interoperability, ARIA ensures that patient data can be utilized effectively across various devices and platforms. It provides comprehensive support for HL7 and DICOM standards, simplifying the transfer of patient data between healthcare facilities. This system grants your teams immediate access to patient information, enhancing their ability to plan and make real-time adjustments as needed. Furthermore, ARIA OIS aids in optimizing image-guided treatment techniques by utilizing radiographic, fluoroscopic, and cone-beam CT images. It also documents activities to support evidence-based Pay-for-Performance initiatives while ensuring compliance with HIPAA regulations. By efficiently storing and organizing patient data and images, ARIA enables your teams to remain informed and dedicated to providing high-quality care for their patients. This innovative system ultimately streamlines workflows, allowing healthcare providers to focus on what truly matters: patient outcomes and well-being.

H1 Universe is an innovative platform that leverages artificial intelligence to enhance the management of healthcare data, offering users access to the most extensive global database of healthcare providers (HCPs). By merging information from various sources, such as public, private, and proprietary databases, H1 Universe provides valuable insights that are crucial for clinical trials, medical affairs, and commercialization efforts. This powerful tool enables healthcare teams to pinpoint essential stakeholders, refine clinical research processes, and make informed decisions swiftly, ultimately boosting overall efficiency within the healthcare landscape. Furthermore, the platform not only aids in real-time decision-making but also fosters collaboration among healthcare professionals, paving the way for improved patient outcomes.

Spend more quality time engaging with your patients while minimizing your interactions with electronic health records, as OncoEMR® prioritizes workflow efficiency and rapid processing. The platform is tailored for oncology practices, featuring specialized workflows and tools like Document Search that streamline tasks, cutting down work duration from minutes to mere seconds. With the introduction of MIPS, OncoEMR® provides essential resources to navigate the program successfully, assisting in the collection and reporting of mandatory data while offering support throughout the workflows and official reporting obligations. Designed specifically for community oncology practices, OncoEMR® incorporates elements such as NCCN Chemotherapy Order Templates® and the latest AJCC disease factors, transforming it into a bespoke diagnostic and treatment resource. Prior to launching OncoEMR®, Flatiron will handle the migration of your existing EHR database, allowing for a seamless transition on your first day of operation. After the migration process, you will benefit from over 150 preloaded reports, enabling you to gain valuable insights into both business operations and clinical metrics, including patient wait times, ensuring a comprehensive understanding of your practice's performance. This combination of tools and features not only enhances efficiency but also supports improved patient care and outcomes in your oncology practice.

Mosaiq serves as an all-encompassing oncology information system and electronic medical record platform that oversees every aspect of cancer care, ranging from diagnosis and treatment strategy formulation to implementation, follow-up, and outcome reporting. This system consolidates clinical, operational, and financial information into one cohesive database, enabling healthcare professionals to obtain comprehensive patient records and enhance collaboration across various specialties, including radiation oncology and medical oncology. Moreover, it facilitates essential workflows like chemotherapy order management, radiation therapy planning and execution, scheduling, billing, and clinical documentation, while also equipping users with decision support tools and customizable workflows to streamline routine processes and boost precision. By integrating these capabilities, Mosaiq significantly enhances the efficiency and effectiveness of cancer care delivery.

ConcertAI stands out as a prominent provider of AI-driven solutions within the healthcare sector, particularly in the field of oncology. Their core mission revolves around enhancing patient outcomes and expediting insights by leveraging top-tier real-world data, cutting-edge AI technologies, and deep scientific knowledge. The company presents an array of products and services aimed at improving both clinical research and patient care experiences. Their Real-World Data Products deliver extensive, customized datasets that cater to diverse research needs across various enterprises. By simplifying clinical trial processes, their digital trial solution ensures efficiency, while the Clinical Trial Optimization (CTO) platform employs extensive AI capabilities to refine the design and implementation of trials specifically in oncology and hematology. Additionally, in partnership with NeoGenomics, ConcertAI has introduced CTO-H, a software-as-a-service (SaaS) solution that concentrates on hematological malignancies, providing sophisticated research analytics and optimizing operational workflows. This integration of advanced technologies not only enhances research capabilities but also significantly contributes to the advancement of patient care in complex medical fields.

Deeplink Medical has centered its offerings around the MIRIO platform, which is designed to cater to the varying use cases and requirements of stakeholders engaged in medical imaging within oncology, both in clinical settings and routine practice. Our services encompass three distinct yet interconnected solutions: MIRIO, which tracks evaluations of solid tumors and monitors the therapeutic responses of oncology patients; a streamlined patient pathway that bridges hospital facilities with private medical practices; and an Imaging CRO dedicated to the oversight of imaging data in oncological clinical trials. The development of our innovative solutions is bolstered by a scientific board, ensuring a robust foundation for our offerings. Additionally, our collaborative workflow platform organizes imaging data and radiological assessments for patients with solid tumors, facilitating real-time data structuration in accordance with RECIST 1.1 and iRECIST guidelines right from the moment the data is generated at investigation sites. This enables immediate evaluation of treatment responses based on established international standards, ultimately enhancing the quality and efficiency of patient care in oncology. By integrating these services, we aim to provide a comprehensive approach that supports healthcare professionals in delivering optimal treatment outcomes.

Inspirata is a specialized oncology data and analytics platform built to help cancer programs improve care delivery and operational performance. It leverages AI-driven technology to automate cancer casefinding, data extraction, and reporting with high accuracy. The platform supports compliance with regulatory requirements while significantly reducing manual registry work. Inspirata transforms unstructured clinical data into actionable insights that fuel research and clinical decision-making. Real-time data access helps improve trial accrual and ensures equitable patient access to clinical studies. Patient navigation tools support coordinated care from screening to survivorship. By improving efficiency, Inspirata allows staff to focus on higher-value patient and research activities. The platform integrates seamlessly with major EHR and clinical systems. Trusted by hundreds of hospitals, Inspirata delivers measurable improvements in oncology operations. It helps cancer centers maximize impact while minimizing cost and complexity.

Omda Cytodose, an oncology medication management solution from Omda, employs clinically validated protocols along with patient-specific parameters to ensure safer and more effective treatments for individuals battling cancer. This innovative system enhances the quality of care provided to oncology patients by fostering a seamless and collaborative treatment process among healthcare professionals, including doctors, pharmacists, and nurses. Omda Cytodose is designed to support a comprehensive range of adult and pediatric cancers, accommodating various medical treatments such as chemotherapy, immunotherapy, hormone therapy, and additional supportive medications. Initially created by a team of clinicians at one of Norway's premier cancer centers and introduced in 2001, Omda Cytodose has gained widespread adoption across healthcare regions in the Nordic countries, leading to the fulfillment of millions of medication orders. With a robust 15-year history marked by stability, reliability, and safety, the system is meticulously configured with chemotherapy protocols that reflect both national and international guidelines. This ensures that patients receive the most up-to-date treatment options available, further enhancing their chances of successful outcomes.

Charm Evolution serves as a comprehensive oncology information management system that centralizes all processes related to chemotherapy prescribing and administration, thereby improving safety, consistency, and accountability by substituting handwritten orders with digital prescriptions that are meticulously monitored through order adjustments and orphan management for precise wastage reporting. It consolidates accurate and secure patient records and treatment data from various sources into a unified database, facilitating informed and efficient decision-making directly at the point of care. Furthermore, an intelligent pathway engine automates treatment protocols, enhances scheduling in accordance with regimens, and caters to both adult and pediatric oncology and hematology through customizable treatment libraries, protocol validation, and management of clinical trials. Additionally, integrated pharmacy management offers bi-directional connectivity with compounders, along with the option to customize worksheets and labels, while the scheduling component maximizes resource allocation and minimizes the need for patient travel, ultimately contributing to a more effective healthcare delivery system. This holistic approach fosters an environment where healthcare providers can deliver optimal care to their patients.

Tempus AI, a prominent health technology firm based in Chicago, Illinois, is dedicated to transforming patient care through advanced artificial intelligence and precision medicine. By utilizing data and AI, the company strives to create personalized treatment plans across a range of medical specialties, such as oncology, cardiology, radiology, and mental health. Their all-encompassing platform combines genomic sequencing, clinical data, and AI-powered analytics, equipping healthcare providers and researchers with actionable insights. Tempus offers a holistic understanding of patients via various testing methods, including tissue and liquid biopsies, DNA and RNA sequencing, somatic and germline tests, as well as tumor-normal matched profiling and minimal residual disease monitoring options. Additionally, they provide a swift and dependable platform for ordering tests, gaining patient insights, and seamlessly integrating AI-driven technologies into practice. Furthermore, Tempus features an innovative generative AI-enabled clinical assistant that places patient insights readily at your fingertips, enhancing the overall efficiency of healthcare delivery. This commitment to leveraging cutting-edge technology exemplifies Tempus AI's mission to improve health outcomes and advance medical research.

Enhance the effectiveness and efficiency of cancer care throughout various healthcare environments. Developed in close partnership with cancer specialists, iKnowMedSM serves as an electronic health record (EHR) that seamlessly offers essential patient information precisely when it’s needed, accessible on nearly any device. Featuring the latest advancements in user interface design and an unparalleled mobile platform, iKnowMed EHR delivers extensive point-of-care treatment decision support alongside customizable features that easily fit into current workflows. Empower your patients with thorough clinical assistance by utilizing a constantly refreshed repository of oncology treatment protocols, drug availability, and clinical outcomes. Gain access to evidence-based clinical guidelines and pathways precisely when required, ensuring timely and effective decision-making. Furthermore, keep your treatment options current by integrating data on treatment expenses, insurance coverage, and reimbursement information, thereby supporting both patients and healthcare providers in navigating the complexities of cancer treatment. In doing so, practices can significantly improve patient outcomes and streamline the overall care process.

Flatiron Health's Evidence Solutions provide a versatile method for generating real-world evidence, both prospective and retrospective, which aids life sciences companies in efficiently meeting their oncology research objectives. At the heart of these offerings is Flatiron Horizon, a comprehensive platform that combines a rich database of more than 5 million anonymized patient records and 1.5 billion data points, coupled with advanced curation techniques and disease-specific machine learning models. This innovative platform is designed to facilitate various phases of the biopharma lifecycle, including discovery, clinical study design, regulatory submissions, and post-marketing commitments. Furthermore, Flatiron's services deliver customized real-world data configurations that cater specifically to oncology, enabling prospective evidence generation through minimally invasive studies and optimizing protocols for better patient identification. Additionally, the platform ensures a streamlined transfer of data from electronic health records to electronic data capture systems with the functionality of Flatiron Clinical Pipe, enhancing overall research efficiency and effectiveness. Such capabilities position Flatiron Health as a leader in transforming oncology research through the power of real-world data.

Brainlab's Elements Contrast Clearance Analysis is an MRI-based technique aimed at distinguishing areas of contrast clearance and accumulation within brain tumor imaging datasets. This advanced high-resolution analysis enhances the understanding required for ongoing evaluations and decision-making across various clinical fields, including radiosurgery, radiation oncology, neurosurgery, neuro-oncology, and neuroradiology. The methodology entails capturing two standard 3D T1-weighted MRIs; the first scan is taken around 5 minutes after administering a standard dose of contrast agent, while the second scan occurs 60 to 105 minutes later. By subtracting the initial series from the subsequent one, volumetric maps are created that clearly identify zones of contrast clearance (shown in blue) against those of contrast accumulation (illustrated in red). These findings empower clinicians to better evaluate the effects of radiation treatment in contrast to potential tumor regrowth, allowing for more educated decisions regarding both initial and subsequent treatment plans. As a result, this analysis not only aids in clinical assessments but also enhances the overall management of patient care in complex cases.

Carevive provides a cancer care management platform that is integrated with electronic health records (EHR) to improve patient outcomes across the entire cancer treatment process. This innovative platform streamlines treatment planning by gathering patient preferences, evaluating interests in clinical trials, and tackling both physical and psychosocial challenges to enhance decision-making processes. During the active treatment phase, Carevive supports remote monitoring of symptoms through electronic patient-reported outcomes (ePROs), offering personalized symptom management plans and evidence-based pathways that aim to elevate quality of life and minimize hospital admissions. After treatment concludes, the platform continues to monitor patient-reported late effects and organizes essential care, which includes diagnostic assessments to identify new or recurring cancers. Furthermore, Carevive's analytics provide insights into aggregated patient experience data, aiding in ongoing quality enhancement and contributing to practical research in oncology. This comprehensive approach ensures that patients receive holistic support throughout their cancer journey, ultimately leading to better health outcomes.

Combine and liberate your disorganized health information through an interactive AI and NLP solution that provides valuable health insights for various stakeholders. This innovative technology serves Providers by hastening the data abstraction process and ensuring the clinical information validation found within notes, thus minimizing the time and costs associated with identifying care gaps, assessing the quality of care through dashboards, and producing registry reports. For Payers, it facilitates the integration and analysis of claims alongside clinical notes, enhancing the management of high-risk and high-cost member populations. In the realm of Life Sciences, this solution enables swift patient matching to clinical trials using databases alongside clinical note data, maximizing the potential of real-world clinical evidence. Ember offers a comprehensive approach that merges NLP with predictive analytics, streamlining healthcare analytics for unstructured data to boost quality, efficiency, and outcomes in the healthcare system. As a result, stakeholders can make informed decisions that lead to improved patient care and resource allocation.

DoseMeRx stands as the first and largest Bayesian dosing platform worldwide, tailored specifically for clinical use. Accelerate your journey toward clinical objectives with our proven platform, which notably enhances patient outcomes while reducing expenses. Uniquely, we are the sole Bayesian dosing solution globally that holds HITRUST certification, providing you with peace of mind regarding the utmost protection and integrity of patient data. Experience seamless continuity of care throughout your healthcare system with just a few simple steps. Easily standardize workflows and fine-tune your therapeutic drug monitoring initiatives. Our diverse array of drug models spans multiple therapeutic fields, such as vancomycin and infectious diseases, transplant medicine, cardiovascular and coagulation management, as well as oncology and pediatrics, ensuring comprehensive support for a wide range of clinical scenarios. This versatility empowers healthcare providers to deliver tailored treatment solutions effectively.

The Innovaccer Health Cloud will accelerate your transformation. You can unify patient data, create comprehensive financial and clinical insights, and innovate faster. We help providers integrate disparate patient information to provide actionable insights at point of care, collaborate across care teams and achieve better outcomes. We facilitate connectivity and collaboration among payers, providers, members, and members to manage risk and compliance as well as rising member expectations. We assist medtech and biopharma companies to build digital solutions at the intersection of healthcare and better use real-world data throughout the value chain. Transform from silos to an open platform that unifies healthcare data into one longitudinal patient record that allows for whole-person care.

Achieving significant advancements in both clinical and administrative outcomes, Evolent Care Partners, a healthcare system in the Midwest, has earned the distinction of being ranked third nationally for both total shared savings and the percentage of savings against benchmarks. By providing independent primary care physicians with essential capital and resources, Evolent Care Partners empowers them to engage in and thrive under two-sided payer contracts while mitigating their financial exposure. New Century Health enhances cost-effectiveness and quality of care in oncology and cardiology by leveraging clinical evidence to inform care decisions, a process that enjoys support from both payers and providers alike. Furthermore, Evolent Health Services streamlines health plan operations through a suite of comprehensive services backed by a modern, integrated platform and a genuine model of strategic partnership. Additionally, the organization encourages exploration of insights and news related to value-based care, population health, health plan administration, and various topics concerning the transformation of healthcare. Through these initiatives, Evolent aims to foster a more efficient and effective healthcare landscape.

Sargas Pharmaceutical Adherence and Compliance (SPAC) International has created an innovative Chronic Care Management Cloud® platform (CCM), alongside its Drug Adherence®, Medication Therapy Monitoring® (MTM), and Mobile Oncology Medication Therapy Monitoring® technologies, to ensure continuous engagement between physicians and patients from the outset of treatment throughout the entire process. This collaborative treatment management strategy not only helps patients maximize their health benefits and achieve optimal outcomes but also contributes to lowering healthcare costs for the system as a whole. Additionally, SPAC offers HIPAA Compliant and certified Chronic Care Management Physician, Patient, and Pharmacy Portals® that facilitate the real-time exchange of essential patient health information among various healthcare providers, ensuring a seamless flow of information critical for effective treatment. Such advancements in technology greatly enhance the overall quality of care delivered to patients.

No matter the scale of your clinic or your location, MOSAIQ Plaza* equips you with the essential digital tools to provide exceptional multidisciplinary care for your patients—ensuring consistency, reliability, and security throughout their journey from diagnosis to survivorship while generating valuable real-world evidence. Elekta has introduced robust solution packages designed to boost your team's ability to provide care and optimize treatment workflows, allowing you to concentrate on your primary focus: your patients. As we pave the way for the future of multidisciplinary cancer care, MOSAIQ 3 establishes new benchmarks in oncology workflow and information management. Experience the advantages of effortless access to the MOSAIQ Plaza environment, which leads to remarkable efficiencies and a more streamlined operational experience, ultimately enhancing patient outcomes and satisfaction.

Our comprehensive primary source dataset stands out as the most extensive and varied resource available for researchers and analysts in the healthcare sector, enabling them to gain profound insights aimed at enhancing both health outcomes and economic efficiency. Propel the future of healthcare by utilizing pertinent data extracts that encompass a wide spectrum of care, featuring detailed provider identification, a comprehensive view of the patient journey, and the capability to securely connect with external data sources. Boost research efforts and elevate healthcare outcomes with longitudinally linkable, deidentified real-world data that is crucial for informed decision-making. We conduct over 1,100 rigorous data integrity checks to guarantee both consistency and precision, employing industry-standard methodologies for quality assurance and seamless integration. Uncover innovative insights through rich and pertinent real-world data. Additionally, harness custom extracts from both open and proprietary primary sources to expedite research processes and enhance clinical outcomes alongside provider performance. Our commitment to data quality and relevance ensures that healthcare professionals can make the best decisions possible.

Utilize analytical insights to minimize variation, enhance the quality of care, streamline care coordination, and manage financial outcomes effectively. Regardless of whether you're functioning within a fee-for-service or a risk-based model, the unparalleled data and analytics capabilities, combined with expert support from Optum® Performance Analytics, can help your organization thrive in the dynamic health care environment. Optum Performance Analytics provides comprehensive clinical and financial longitudinal perspectives on your patients, healthcare providers, facilities, and networks. By merging your varied clinical and claims data with an expanding array of sociodemographic, behavioral, and patient-reported information, you gain a deeper understanding and context. Additionally, Optum Performance Analytics is designed with the adaptability to align with the objectives of any healthcare system. Organizations that need focused guidance can take advantage of pre-built dashboards and opportunity reports that identify ways to improve care and cut costs, ultimately paving the way for more effective health management strategies. As such, adopting these analytics tools not only fosters better patient outcomes but also strengthens the overall operational efficiency of healthcare providers.

Enhance both patient experiences and health outcomes while ensuring the success of medical practices in the fast-evolving field of oncology. Canopy’s Intelligent Care Platform serves as a comprehensive suite of interoperable software solutions that integrates seamlessly with EMR and Practice Management systems, allowing healthcare providers to offer superior care to a larger patient base at reduced costs. Boost revenue by maximizing treatment duration and effectively implementing reimbursement strategies, all while improving quality metrics within the practice. Our remote monitoring tools, triage algorithms, and symptom management pathways contribute significantly to better patient outcomes and overall quality of life. Additionally, we optimize incoming call workflows, facilitating better task management and fostering collaboration across various departments and locations, ultimately leading to more cohesive and efficient patient care.

Suvoda is a worldwide leader in clinical trial technology, focusing on intricate, life-preserving studies in fields like oncology, central nervous system conditions, and rare diseases. Established in 2013, the company provides a comprehensive platform featuring Interactive Response Technology (IRT), electronic Consent (eConsent), electronic Clinical Outcome Assessments (eCOA), and ePatient solutions, all aimed at streamlining essential patient interactions. Their innovative software design guarantees a fluid user experience, enabling accurate randomization, efficient drug supply management, and immediate data collection. With a strong commitment to improving patient understanding and alleviating the demands on trial sites, Suvoda's offerings are designed to evolve alongside the increasing complexities of clinical trials. Based near Philadelphia, with additional offices across Europe and Asia, Suvoda has successfully supported over 1,500 trials in more than 85 countries, showcasing their global reach and expertise in the field. Their dedication to innovation and excellence positions them as a vital partner in the advancement of clinical research.

Mahalo Health is an integrated digital health platform aimed at expediting the creation of patient-focused digital health solutions and clinical trials. By providing a variety of prebuilt modules, Mahalo facilitates the swift launch of customizable white-label applications that cater to particular therapeutic fields. The platform boasts comprehensive data capabilities, featuring a predictive health engine for forecasting diseases and diagnoses, a behavior modification engine to encourage beneficial patient behaviors, and a notification system that ensures timely communication through push notifications, SMS, or emails. Committed to maintaining high security and compliance standards, Mahalo follows regulations such as HIPAA, GCP, ISO27001, and GDPR. Its extensive range of services encompasses multiple therapeutic areas, including diabetes, cognitive health, cardiovascular issues, musculoskeletal conditions, mental health, oncology, rare diseases, and nonalcoholic steatohepatitis (NASH). Additionally, Mahalo Health empowers healthcare providers with tools to enhance patient engagement and outcomes through its innovative digital solutions.

Oncology-Cloud, developed by WRS Health, transcends the typical EHR and Practice Management software by offering a comprehensive platform crafted by medical professionals. This integrated solution focuses on clinician-oriented workflows, aiming to enhance and expand your practice consistently. Additionally, Oncology-Cloud’s Business Process Outsourcing (BPO) service adopts a consultative strategy, collaborating with you and your team to assess and establish targeted KPIs for your practice. Through our established methodology, we support you in accomplishing these objectives and refining your practice operations. By prioritizing a partnership approach, we ensure that your practice can thrive in a competitive healthcare landscape.

Foundations™ integrates financial, clinical, and operational data, offering a comprehensive view accessible to your entire team via a user-friendly visualization interface. This tool not only helps uncover new operational insights but also allows clinicians, staff, and administrators to track dashboards that reveal inefficiencies and identify necessary steps to enhance patient care and ensure business success. Acting as the ultimate “source of truth,” Foundations™ equips each team member to make informed decisions with confidence. By enhancing the quality of documentation across various fields, including workflow states and case details, the platform contributes to a decreased rate of complications for each case. As a result, patients experience better overall clinical outcomes. Foundations™ effectively empowers clinicians by delivering real-time operational data in a visually compelling format for immediate action, ultimately leading to improved patient health outcomes. Furthermore, it provides clinicians with a quick and efficient way to evaluate their performance against their peers and established goals, facilitating a deeper understanding of clinical metrics and fostering continuous improvement. This holistic approach ensures that all team members are aligned in their efforts to enhance patient care and operational efficiency.

We facilitate the transition to value-based healthcare by evaluating various treatments, medications, processes, and costs, which aids hospitals, life sciences firms, and payers in pinpointing the most effective treatment strategies for optimal patient results. Our CRCA™ P&T platform equips Pharmacy and Therapeutics committees to implement data-driven enhancements in key quality indicators, including metrics like average length of stay (ALOS) and 30-day readmissions. The innovative POP-BUILDER Rx™ solution offers comparative evaluations among chosen cohorts against CRCA’s extensive real-world data index, which encompasses over 140 million longitudinal patient records. Additionally, our drug remittance dashboard provides an in-depth analysis and reporting of drug remittance information across different payer categories, focusing on high-cost medications at the National Drug Code (NDC) level. Furthermore, we assist hospital finance teams in effectively tracking and enhancing service line costs and profitability, productivity, and revenue cycle performance through our insightful analytics, detailed reporting, and the expertise of our Agilum Healthcare Intelligence team. This comprehensive approach ensures that healthcare providers can make informed decisions that positively impact both operational efficiency and patient care.

The Clinical Insights Manager is a comprehensive cloud-based platform that serves enterprise healthcare needs by capturing, storing, and analyzing detailed retrospective patient data from both Philips and other medical devices, allowing organizations to convert extensive clinical information into practical insights. With its open and scalable design, the platform consolidates and refines high-resolution data, including diagnostic-quality ECG, and displays this information through user-friendly dashboards that facilitate easy navigation, querying, and analysis of intricate datasets. By maintaining data integrity and ensuring thorough access to past patient information such as waveforms, numerics, and alarm events, it aids in enhancing quality improvement, managing alarms, supporting research initiatives, and boosting operational efficiency. Additionally, it features applications like Alarm Insights Manager, Data Viewer, and Telemetry Insights Manager, which offer essential tools for assessing alarm performance and optimizing clinical workflows. This robust system ultimately empowers healthcare providers to make informed decisions backed by reliable data.

At ArborMetrix, our aim is to enhance healthcare through data science, while our enthusiasm lies in providing impactful, user-friendly technology and analytics. Our advanced healthcare analytics solutions are designed to yield precise, clinically-rich insights that enhance clinical outcomes, boost financial effectiveness, add value for stakeholders, and evaluate the real-world success of treatments, procedures, medical devices, and pharmaceuticals. One of the significant benefits of patient registries is their application across various medical fields, with post-market surveillance standing out as a particularly important function. To assist you in establishing a reliable data resource, we follow a systematic approach. First, it’s essential to have an effective and secure method for gathering substantial amounts of real-world data, which is crucial for thorough analysis. By utilizing the appropriate technology, you can aggregate data from diverse sources such as medical records, regulatory bodies, and patient-reported outcomes to support post-market surveillance initiatives. This comprehensive approach not only streamlines the data collection process but also enhances the overall quality of insights derived from the analysis.

LexisNexis® MarketView™ provides medical claims-based insights tailored for healthcare payers, providers, life sciences enterprises, and health IT organizations throughout the United States. This platform offers actionable intelligence designed to enhance competitiveness, enabling businesses to uncover valuable insights and visualize transformative strategies. Regardless of whether you represent a life sciences firm, a health insurance plan, a healthcare system, or a health IT service provider, MarketView can significantly enhance critical business processes such as marketing, sales, strategic planning, physician engagement, outreach, market research, network optimization, talent acquisition, pricing strategies, contracting, and clinical management, among others. To stay ahead in the competitive landscape, your organization requires the most relevant insights available. However, determining the right areas to focus on can be challenging when the overall picture lacks clarity. MarketView addresses this issue by providing insights into various aspects such as referral trends, strategies for aligning with physicians, the performance of clinically integrated networks, and patient volume metrics, ultimately empowering organizations to make informed decisions. By leveraging these insights, businesses can drive innovation and improve their operational effectiveness.

AppliedVR stands at the forefront of therapeutic virtual reality, revolutionizing the healthcare landscape through innovative digital experiences. Established in 2015, the company has successfully provided scientifically validated digital health solutions to over 20,000 patients across more than 250 hospitals in eight countries worldwide. Their premier digital wellness platform has made a significant impact on the management of chronic pain and acute anxiety related to various medical procedures, including surgery, childbirth, oncology treatments, emergency interventions, and rehabilitation. The appliedVR methodology draws from over three decades of academic research and is influenced by prominent figures in scientific VR and esteemed medical professionals. With a diverse range of medical and consumer products in development, our mission is to create the leading digital platform for pain management and to redefine treatment approaches in hospitals, clinics, and home settings. As we continue to innovate and expand, we are committed to improving patient experiences and outcomes in pain management across the globe.

Microsoft Cloud for Healthcare serves as an all-encompassing platform aimed at revolutionizing the healthcare sector by utilizing AI-driven solutions, integrating data, and ensuring secure, interconnected experiences. This platform assists healthcare providers, payors, and life sciences entities in enhancing patient care, optimizing operations, and bolstering research efforts. It provides resources for protecting confidential information, streamlining clinical processes, and fostering better patient engagement. By harnessing actionable insights derived from integrated clinical and operational data, Microsoft Cloud for Healthcare empowers organizations in the healthcare field to achieve favorable results, boost efficiency, and lower expenses. Ultimately, this innovative platform is pivotal in shaping the future of healthcare delivery.

We are excited to unveil a groundbreaking continuous care platform that aims to enhance patient care significantly. GBS’ Remote Patient Monitoring (RPM) system is designed for physicians and hospitals, allowing healthcare providers to deliver exceptional medical services remotely, fostering strong patient loyalty and genuine engagement. As healthcare systems increasingly prioritize continuous care, this innovative approach offers substantial advantages to both patients and medical practices alike. With advanced technology, continuous care can now be achieved outside of traditional clinical environments, such as in the familiar surroundings of the patient's home. The devices are user-friendly and come pre-configured for immediate use, catering to conditions like hypertension, diabetes, heart failure, and oncology. These "senior simple" devices automatically send vital signs to both the electronic health records and the care team, ensuring seamless communication and monitoring. Ultimately, this platform not only streamlines patient management but also empowers healthcare providers to focus on delivering top-tier care.

Effectively managing large volumes of data is essential for both the well-being of your organization and the patients it serves. However, undertaking such initiatives can often lead to significant demands on both time and resources. Fortunately, Business & Clinical Analytics (BCA) takes on the challenging aspects for you. This web-based data visualization platform is designed to enhance organizational efficiency, track progress, and boost overall performance. Its implementation is straightforward, it's user-friendly, and it seamlessly integrates with MEDITECH's EHR, allowing you to leverage your clinical, financial, and operational data effectively to guide your organization toward success. Given the extensive information you handle, it necessitates meticulous care and ongoing maintenance. To simplify this process, BCA is equipped with standard dashboards that help visualize your organization's data, ensuring you can swiftly activate your big data initiatives. Moreover, MEDITECH regularly updates your dashboard library, continually introducing new dashboards and analytical tools that include a range of selectors to filter data by various criteria such as time frames, providers, payers, and patient categories, thus further enhancing your analytical capabilities. This ongoing commitment to innovation ensures that your organization remains agile in the ever-evolving landscape of healthcare data management.

Pareto Intelligence is an innovative platform specializing in healthcare analytics and technology aimed at enhancing the financial performance and compliance of health plans and risk-bearing provider organizations while also improving clinical communication and outcomes in value-based care. At its foundation lies a centralized healthcare data environment that assimilates, normalizes, and enriches a variety of clinical, claims, and social determinants of health data, enabling comprehensive views of patients and programs that facilitate advanced analytics and reporting. Among its offerings are tools for risk adjustment and revenue integrity that reveal undocumented risk gaps, enhance risk scores, aid in RADV audit preparedness, reconcile premiums, and guarantee complete and compliant revenue capture. Additionally, Pareto provides payment integrity solutions designed to identify both under- and overpaid claims, thereby enhancing Section 111 reporting and the coordination of benefits. By leveraging these capabilities, healthcare organizations can make informed decisions that lead to improved patient outcomes and operational efficiency.

The advanced features of the Inovalon ONE® Platform enable our clients and collaborators to thrive by utilizing extensive industry connections, vast primary-source real-world data, advanced analytics, and robust cloud-based technologies to enhance healthcare outcomes and economics. Central to modern healthcare is the necessity to consolidate and scrutinize vast amounts of varied data, extract valuable insights from these analyses, and apply this knowledge to effect significant improvements in patient outcomes, operational performance, and healthcare economics. With analytics and capabilities employed by over 20,000 clients, we draw upon the primary source data from more than 69.5 billion medical events, encompassing one million healthcare professionals, 611,000 clinical environments, and 350 million distinct patients. This extensive network of data and analytics is crucial for driving innovation and efficiency in the healthcare sector, fostering an environment where informed decisions lead to substantial advancements.

Enhance the capabilities of your agency and sales force by providing immediate access to market intelligence and sales data. Focus on referral sources that align with their patient demographics and discharge trends, integrating them into your sales pipeline for better tracking. Pay attention to the clinical classifications of patients along with their discharge behaviors to effectively build your network. Assess your agency's performance by analyzing readmission statistics, diagnostic metrics, and payer distribution. Improve your sales strategy and increase conversion rates through tailored dashboards and reports for both individual representatives and teams. Cultivate referrals and foster stronger connections through comprehensive customer profiles, accessible from any mobile device, alongside guided talking points. Equip hospice sales teams with essential data and predictive clinical indicators to facilitate timely care for more hospice patients. Investigate, analyze, and benchmark the demographics and treatment histories of hospice patients to ensure they recognize the advantages of hospice care, thereby enhancing overall service delivery and patient outcomes. By leveraging these insights, your agency can strategically position itself to meet the growing demands of hospice care effectively.

HRA® (Healthcare Research & Analytics) is a comprehensive market research firm specializing in the healthcare sector, offering exclusive access to a proprietary panel that includes physicians, payers, patients, caregivers, pharmacists, and other essential stakeholders to enhance your brand strategy. With over 100,000 community-based healthcare professionals and influential opinion leaders contributing valuable insights on critical issues, HRA® ensures you receive the information necessary for your success. Drawing on more than 75 years of collective experience in collaboration with healthcare companies, HRA® delivers insights and guidance essential for pre-launch, launch, and post-launch phases. The agency supports your commercial objectives by developing brand strategies, executing them, and providing real-time evaluations of stakeholder attitudes and behaviors. HRA® offers tailored strategic solutions to a diverse range of healthcare clients, combining clinical knowledge with commercial acumen and innovative strategies to keep you at the forefront of the healthcare landscape. Their commitment to understanding the dynamics of the healthcare community positions them as an invaluable partner in navigating industry challenges.

Merlin's CardioMotionTM echo analysis and reporting software, distributed by CDN in Australia, revolutionizes support for swiftly identifying cardiac problems. Designed for use in emergency medicine, CCU/ICU settings, oncology departments, medical center clinicians, ultrasound facilities, cardiology units, and even in regional or remote locations that rely on point-of-care devices, it also proves advantageous for cardiac monitoring during clinical trials. What sets Merlin CardioMotionTM apart is its ability to process slow frame rate echo clips accurately without needing an ECG trace for detection, making it compatible with lower-specification ultrasound machines. Employing groundbreaking image processing technology, it is built upon a foundation of proprietary algorithms that facilitate the automatic identification of the ventricular wall and its borders. This innovative approach allows for a swift and precise quantitative evaluation of the heart's dynamic functioning, ultimately enhancing patient care. With its capabilities, healthcare providers can make informed decisions and improve outcomes in cardiac health management.

We gather comprehensive patient data to provide you with an invaluable tool for comprehending patient behaviors and requirements. Our platform, PharmDash, organizes this information into an easily navigable interface that allows for rapid filtering, giving you immediate access to cross-sectional views of your targeted patient populations. This enables you to identify who is in need of your treatments and to determine the areas where your pharmaceutical influence should be strengthened. Furthermore, the predictive capabilities of our machine learning analytics allow you to anticipate which patient groups may need your specific treatments in the future. With Prospection, you can effectively plan your resource allocation and remain informed about emerging trends in the pharmaceutical landscape. This ensures that you can pinpoint the right patients at the optimal time for intervention. Leveraging historical data not only provides you with a competitive advantage in identifying your target demographics but also offers solid evidence to connect patients with appropriate treatment options, ultimately enhancing patient care. As a result, you can make more informed decisions that align with both patient needs and market dynamics.

Value-driven care relies heavily on timely, precise, and trustworthy information. Utilize the Minerva Healthcare Data Platform to consolidate both clinical and claims information from various systems into a centralized FHIR® repository. With its foundational design based on FHIR® and a commitment to being vendor-neutral, Minerva compiles data from your care delivery network, facilitating data exchange, enhancing analytical capabilities, and ensuring compliance with Cures Act requirements. The platform offers a suite of ready-to-use data connectors that enable swift data ingestion from diverse clinical and claims sources. Take advantage of established healthcare standards and tailor-made data formats to incorporate information in real-time or through batch processing. By integrating data from your clinical network alongside that from your payers, you can create a comprehensive view of your patients' information, ultimately leading to improved care outcomes. This holistic approach not only streamlines operations but also fosters a deeper understanding of patient needs.

Fujifilm's Synapse 3D represents a cutting-edge visualization solution that has been crafted in conjunction with a variety of medical professionals, including radiologists, cardiologists, and surgeons, providing more than 50 applications designed to improve both the accuracy and efficiency of diagnoses. This platform features advanced server-side technology that accommodates both cloud and on-premise hosting, enabling sophisticated image analyses that aid in interpretation, reporting, and treatment planning while promoting effective clinical collaboration throughout the organization. It addresses specialty fields such as cardiology, pulmonology, oncology, urology, neurology, and gastroenterology, showcasing its versatility. The architecture of Synapse 3D is scalable, allowing for unlimited expansion, and its reliable workflows boost overall productivity while catering to extensive visualization requirements through specialized applications. The platform also includes native cardiology features that enhance cardiac care, and its AI-driven detection capabilities significantly enhance the accuracy and efficiency of interpretations. Additionally, Synapse 3D offers seamless integration with Fujifilm's Synapse Enterprise PACS, making it an invaluable resource for healthcare providers seeking to optimize patient outcomes. With these comprehensive features, it stands to revolutionize the way medical imaging is approached in clinical settings.

Individuals globally are plagued by intricate illnesses and a wide array of symptoms. Yet, they all have one crucial requirement in common: the urgent demand for the quicker creation of safer and more efficient treatments. Owkin’s goal is to enable researchers in hospitals, universities, and pharmaceutical firms to comprehend the reasons behind variations in drug effectiveness among patients, streamline the drug development process, and pinpoint the optimal medication for each individual to enhance therapeutic results. Central to Owkin's research ecosystem is Owkin Loop, which links medical researchers with high-quality datasets sourced from top academic research institutions worldwide. This innovative platform is driven by two primary elements of Owkin's Software Stack: Owkin Studio, a machine learning platform, and Owkin Connect, which serves as a federated learning framework. Additionally, Owkin is actively engaged in medical research collaborations across various fields, including Oncology, Immunology, and Cardiovascular diseases, showcasing the breadth of its commitment to improving patient care. Their collaborative efforts reflect a dedication to transforming healthcare through advanced technology and data-driven insights.

Jvion transcends conventional predictive analytics by uncovering concealed patient risks associated with various diseases and clinical scenarios while also assessing whether those risk patterns can be redirected toward more favorable outcomes. Utilizing our prescriptive AI, we offer tailored recommendations for individual patients by considering a range of factors, including clinical, socioeconomic, and behavioral data, along with established best practices. With this insightful information, healthcare organizations are empowered to enhance quality, reduce costs, and elevate the overall patient experience. We analyze a wide array of clinical, socioeconomic, environmental, and behavioral data to uncover hidden health and financial vulnerabilities. By evaluating modifiable patient characteristics, we can formulate targeted action plans for each individual. Our approach delivers evidence-backed, prioritized, and patient-specific recommendations that seamlessly align with existing workflows. In light of the ongoing pandemic, the concept of home care has gained renewed significance, as many patients now prefer to seek treatment at home to minimize the risk of exposure to Covid-19 and other illnesses. This shift underscores the necessity for innovative healthcare solutions that cater to the evolving needs of patients in a post-pandemic world.